ASTH insiders

15 insiders have filed at ASTH since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Lam Thomas S.Director7.69M15.678%nonenone
Sim Kenneth T.Executive Chairman7.59M15.477%nonenone
Young Albert WaichowChief Administrative Officer7.13M14.54%nonenone
Allied Physicians Of California, A Professional Medical Corp10% owner6.13M12.502%nonenone
Sim BrandonCEO And President1.70M3.459%nonenone
Kumar Dinesh M.Chief Medical Officer200.3k0.408%nonenone
Basho ChandanCOO And CFO173.7k0.354%nonenone
Marsh LindaDirector92.6k0.189%nonenone
Mazdyasni MatthewDirector34.8k0.071%nonenone
Schmidt DavidDirector31.5k0.064%nonenone
Chiang JohnDirector30.8k0.063%nonenone
Kitayama Mitchell WDirector27.8k0.057%nonenone
Vong JohnChief Accounting Officer17.5k0.036%nonenone
Sobotka GlennChief Accounting Officer14.0k0.029%nonenone
Dai, WeiliDirector13.7k0.028%nonenone

No open-market buys or sells have been reported at ASTH since 2023Q3. The table shows the filed stakes; it updates when an insider files.

Full register at boothcheck.com/insiders/ASTH. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

ASTH institutional holders · ASTH research report